Significance
Extracellular tissue debris accumulates with aging and in the most prevalent central-vision-threatening eye disorder, age-related macular degeneration (AMD). In this work, we discovered that lysosome-associated membrane protein-2 (LAMP2), a glycoprotein that plays a critical role in lysosomal biogenesis and maturation of autophagosomes/phagosomes, is preferentially expressed in the outermost, neuroepithelial layer of the retina, the retinal pigment epithelium (RPE), and contributes to the prevention of ultrastructural changes in extracellular basolaminar deposits including lipids and apolipoproteins. LAMP2 thus appears to play an important role in RPE biology, and its apparent decrease with aging and in AMD specimens suggests that its deficiency may accelerate the basolaminar deposit formation and RPE dysfunction seen in these conditions.
Keywords: lysosome, LAMP2, retinal degeneration, aging
Abstract
The early stages of age-related macular degeneration (AMD) are characterized by the accumulation of basal laminar deposits (BLamDs). The mechanism for BLamDs accumulating between the retinal pigment epithelium (RPE) and its basal lamina remains elusive. Here we examined the role in AMD of lysosome-associated membrane protein-2 (LAMP2), a glycoprotein that plays a critical role in lysosomal biogenesis and maturation of autophagosomes/phagosomes. LAMP2 was preferentially expressed by RPE cells, and its expression declined with age. Deletion of the Lamp2 gene in mice resulted in age-dependent autofluorescence abnormalities of the fundus, thickening of Bruch’s membrane, and the formation of BLamDs, resembling histopathological changes occurring in AMD. Moreover, LAMP2-deficient mice developed molecular signatures similar to those found in human AMD—namely, the accumulation of APOE, APOA1, clusterin, and vitronectin—adjacent to BLamDs. In contrast, collagen 4, laminin, and fibronectin, which are extracellular matrix proteins constituting RPE basal lamina and Bruch’s membrane were reduced in Lamp2 knockout (KO) mice. Mechanistically, retarded phagocytic degradation of photoreceptor outer segments compromised lysosomal degradation and increased exocytosis in LAMP2-deficient RPE cells. The accumulation of BLamDs observed in LAMP2-deficient mice was eventually followed by loss of the RPE and photoreceptors. Finally, we observed loss of LAMP2 expression along with ultramicroscopic features of abnormal phagocytosis and exocytosis in eyes from AMD patients but not from control individuals. Taken together, these results indicate an important role for LAMP2 in RPE function in health and disease, suggesting that LAMP2 reduction may contribute to the formation of BLamDs in AMD.
Cellular and extracellular debris accumulate in age-associated disorders such as atherosclerosis, Alzheimer disease, and age-related macular degeneration (AMD). AMD is the leading cause of central vision loss in developed countries and exists in 2 forms: the neovascular or “wet” form (∼15%) and the nonneovascular or “dry” form (85%) (1, 2). Dry AMD, for which effective treatments are elusive (1), is characterized by a particular form of extracellular debris accumulating with age, the so-called drusen (3, 4). Importantly, large drusen are associated with the risk of developing late AMD—namely, neovascular AMD or geographic atrophy (5). Histopathological examination of AMD specimens has identified material between the retinal pigment epithelium (RPE), a monolayer of cells beneath the neurosensory retina, and the underlying Bruch’s membrane (BrM). The debris accumulating beneath the RPE can be classified into 2 categories: basal linear deposits (BLinDs) and basal laminar deposits (BLamDs). BLamDs are the most prevalent histopathologic finding in early AMD (6). However, the mechanism of BLamD generation remains unclear.
One of the major functions of RPE cells is the phagocytosis of photoreceptor outer segments (POSs) that are shed daily from retinal photoreceptor cells. Phagocytic removal of POSs may be involved in a unique age-related change in the RPE, lipofuscin accumulation. The cargo of lipofuscin granules includes the remnants of POSs that are being degraded (7, 8). Although the biogenesis of lipofuscin and drusen is different (9–13), it has been suggested that at least some druse material may come from POSs (14, 15), meaning that lysosomal (dys)function might be relevant to AMD. Kim et al. have shown that phagocytic POS digestion in the RPE requires ATG5-dependent recruitment of LC3 to the phagosome (16). Previous immunohistochemical studies on cadaveric eyes from AMD patients revealed the presence of autophagy-related proteins in drusen (17, 18). Furthermore, knockout of RB1-inducible coiled-coil 1 (RB1CC1; also known as FIP200), an upstream inducer of autophagy, results in RPE dysfunction. Deletion of a gene coding for another multifunctional protein, crystallin beta-A1 (CRYBA1), which regulates endolysosomal acidification, also results in RPE dysfunction in animal models (19–21). These human and animal data taken together suggest that the lysosomal/autophagic pathway may contribute to RPE physiology as well as to AMD pathology.
Lysosome-associated membrane protein-2 (LAMP2) is a rather abundant lysosomal glycoprotein that functions as a receptor for proteins to be imported directly into lysosomes and as a mediator for autophagosomal/phagosomal maturation (22–28). Lamp2 knockout (KO) mice are characterized by disrupted autophagy and phagocytosis in hepatocytes, neurons, and leukocytes (23–26). Loss-of-function mutations of the human LAMP2 gene cause Danon disease, a lysosomal storage disorder characterized by cardiomyopathy, skeletal myopathy, and mental retardation (29, 30). Importantly, recent studies have revealed that patients with Danon disease also exhibit progressive retinal degeneration, indicating that LAMP2 may be essential for retinal homeostasis (31–34).
In this study, we investigated the role of LAMP2 in retinal physiology and age-related retinal pathology. We observed that LAMP2 was primarily expressed by RPE cells, and that its deletion in mice resulted in accelerated age-dependent accumulation of autofluorescent granules and BLamDs, as well as in thickening of BrM, the collagenous and elastic layers between the basement membrane of the RPE and that of the choriocapillaris. Consistently, we discovered a decreased expression of LAMP2 and disrupted lysosomal structures in the human RPE from AMD patients compared to control subjects. Altogether, these results suggest that LAMP2 deficiency facilitates the formation of sub-RPE material and hence may contribute to the pathogenesis of AMD.
Results
Preferential Expression of LAMP2 in the RPE and Effects of Aging.
To investigate the role of LAMP2 in RPE health and disease, we first examined LAMP2 expression in the neurosensory retina and the RPE/choroid from mice. By immunoblotting, significantly higher levels of LAMP2 protein were detected in the RPE compared to the retina (Fig. 1A). The observed band in the RPE corresponded to mature, extensively glycosylated LAMP2, resulting in an apparent molecular weight of ∼100 kDa (35). In contrast, significantly less LAMP2 was observed in the retina, displaying a slightly lower molecular weight (Fig. 1A), presumably due to less glycosylation. Of note, these immunoreactivities observed in wild-type (WT) mice were completely absent in Lamp2 KO mice, validating the specificity of the antibody. Next, we compared LAMP2 expression in isolated RPE cell monolayers from young and aged WT mice. As normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or the RPE specific marker protein RPE65, LAMP2 expression decreased at 12 mo compared to 2 mo of age (Fig. 1B). Furthermore, the levels of sequestosome 1 (SQSTM1; also known as p62), an autophagosome cargo protein, significantly increased in the RPE/choroid of 12-mo-old WT mice compared to its levels in 2 mo-old mice, suggesting an impairment of autophagic flux (Fig. 1C). Altogether, these findings suggest a critical role for LAMP2 in the RPE that can be affected by age.
LAMP2-Deficient Mice Exhibited Age-Dependent Fundus Abnormality, Basal Laminar Deposits, and Thickening of Bruch’s Membrane.
We examined the ocular phenotype of LAMP2-deficient mice over time by means of fundus photography and fundus autofluorescence (FAF). Fundus photography revealed patchy pigmentary abnormalities that increased with age in 6–12-mo-old Lamp2 KO mice; these features were absent or attenuated in age-matched WT mice (Fig. 2A and SI Appendix, Fig. S1). More strikingly, we observed an age-dependent increase in punctate FAF in Lamp2 KO but not in WT mice (Fig. 2B). Fluorescent microscopy at the same wavelength as the clinical FAF images (488 nm) also detected an increase in autofluorescent granules in RPE cells (Fig. 2C). Since the subretinal microglial cells may be a source of FAF in aged mice (36–38), we quantified such cells by Iba-1 immunofluorescence in RPE flatmount specimens. Notably, subretinal Iba-1–positive cells were less abundant in Lamp2 KO than in WT mice (SI Appendix, Fig. S2), contrasting with the autofluorescence that was higher in Lamp2 KO RPE flatmounts than in WT controls (SI Appendix, Fig. S3). These findings indicate an increased abundance of autofluorescent granules in RPE of LAMP2-deficient mice.
To further characterize the changes seen in the fundus examination, electron microscopy examination of the RPE and the sub-RPE space was performed. BLamDs are located between the RPE and its basal lamina; they consist of amorphous material that is similar in electron density and texture to the basal lamina (39). In contrast, a BLinD is membranous material located between the basal lamina of the RPE and the inner collagenous layer. Moreover, BLamD thickness correlates with the degree of RPE degeneration, photoreceptor fallout, and vision loss (40–42). Similar to human AMD (39), amorphous BLamDs were observed in 6-mo-old Lamp2 KO mice, contrasting with minimal sub-RPE deposits in age-matched WT mice, which became more prominent at 12 mo of age (Fig. 3A). Ultrastructural examination detected granular electron-dense structures within BLamDs (Fig. 3A; arrows). The electron-dense material in the electron-lucent tracks crossing the deposits may be partly preserved lipids, similar to prior findings in humans (43) and mice (44). Such granular debris appeared to be exocytosed from the RPE into the basolateral extracellular space (Fig. 3A; arrows). An accumulation of lipid droplet–like inclusions was observed in 12-mo-old Lamp2 KO mice (Fig. 3B; asterisks in image). Consistently, oil red O staining revealed lipid droplets in the RPE of Lamp2 KO mice (Fig. 3C). In addition, LAMP2 deficiency led to the progressive thickening of BrM, a 5-layer connective tissue sandwiched between the RPE and the choriocapillaris, with age (Fig. 3D). The thickened BrM exhibited intense periodic-acid-Schiff (PAS) positivity, and the thickness of PAS-positive structures was higher in Lamp2 KO than in WT retinas (Fig. 3E), resembling the characteristic of aged human BrM (45, 46).
Furthermore, histological and functional examination of Lamp2 KO retinas showed that RPE dysfunction was accompanied by an age-dependent loss of photoreceptors (referred to as “ONL” in SI Appendix, Fig. S4) from 2 to 12 mo (SI Appendix, Fig. S4). This finding is reminiscent of the death of overlying photoreceptors and concomitant retinal thinning associated with RPE dysfunction in dry AMD (47–49).
Molecular Characterization of Sub-RPE Deposits in LAMP2-Deficient Mice.
We next characterized molecules in sub-RPE deposits in Lamp2 KO mice by Western blotting. Key proteins found in human drusen, such as apolipoprotein E (APOE), clusterin (CLU), and vitronectin (VTN), were significantly up-regulated in Lamp2 KO mice compared to WT mice at 6 mo of age (Fig. 4A). Immunofluorescence studies confirmed the accumulation of these molecules under the RPE (Fig. 4B). The overexpression of APOE was confirmed in ex vivo cultures of primary RPE from Lamp2 KO mice compared to the WT control RPE (SI Appendix, Fig. S5), indicating that RPE cells may be the source of APOE contained in sub-RPE deposits. Immunofluorescence analysis also revealed that extracellular matrix proteins such as collagen IV, laminin, and fibronectin decreased in Lamp2 KO mice compared to WT mice at 12 mo of age. The decreased expression of laminin and fibronectin in the Lamp2 KO RPE/choroid was confirmed by Western blot analysis (SI Appendix, Fig. S6). In contrast, expression of matrix metalloproteinase 2 (MMP-2) increased in the Lamp2 KO RPE/choroid (SI Appendix, Fig. S6). We further examined alterations in lipids in Lamp2 KO eyes. LAMP2 deficiency resulted in increased expression of APOA1 but not of APOB (Fig. 5). Filipin staining unraveled the accumulation of unesterified cholesterol (UC) under the RPE in Lamp2 KO mice (Fig. 5). Moreover, an increase in accumulation of esterified cholesterol (EC), which is specific for drusen and BrM depositions in human eyes (50, 51), was observed on the basal side of the RPE in Lamp2 KO mice. These results suggest that the BLamDs found in Lamp2 KO mice are associated with accumulation of lipids and decreased abundance of extracellular matrix.
Deficient POS Phagocytosis and Increased Lysosomal Exocytosis in LAMP2 KO Mice Aids the Formation of Sub-RPE Deposits.
Given the extensive sub-RPE deposits observed in Lamp2 KO mice, we further examined the underlying cellular and molecular mechanisms. Phagocytosis of POSs is one of the important functions of the RPE (52, 53). Transmission electron microscopy (TEM) confirmed the increased number of POS phagosomes in the RPE of Lamp2 KO mice compared to that of WT mice at 2 mo of age (Fig. 6A). This difference was accentuated at 6 mo of age, when most of the POS phagosomes in Lamp2 KO mice adopted a notably dilated morphology (Fig. 6A; arrowheads). Furthermore, the RPE from 6-mo-old Lamp2 KO mice manifested an augmentation of total microtubule-associated proteins 1A/1B light chain 3 (LC3), an increase in the ratio of lipidated to nonlipidated LC3 (LC3-II/I ratio), an augmentation of SQSTM1 (Fig. 6B), and an increase in accumulation of autophagic vacuoles (Fig. 6C). The accumulation of LC3-II might result from a disruption of autophagy and/or LC3-associated phagocytosis (LAP) (16), whereas SQSTM1 accumulation suggested reduced macroautophagy. To further examine whether impaired (auto-)phagocytic digestion contributes to extracellular deposit formation, ex vivo cultures of primary RPE cells were examined in the presence or absence of exogenously supplied POSs. The RPE from Lamp2 KO mice showed a significant accumulation of basolateral deposits, which was more pronounced in the presence of POS feeding (Fig. 7) when compared to the WT mice RPE.
To further examine if impaired autophagy/phagocytosis and BLamD formation in LAMP2-deficient RPE cells was associated with lysosomal exocytosis, we performed a lysosomal enzyme release assay by measuring extracellular beta-hexosaminidase activity in RPE cells. Lamp2 gene silencing was achieved by a specific siRNA that did not affect LAMP1 expression in the human RPE cell line, ARPE-19 (SI Appendix, Fig. S7). In LAMP2-deficient ARPE-19 cells, extracellular beta-hexosaminidase activity was significantly increased upon stimulation of calcium-mediated lysosomal exocytosis by ionomycin (SI Appendix, Fig. S7), indicating an up-regulated ability of lysosomal exocytosis in LAMP2-deficient cells.
Taken together, these data suggest that impaired phagocytic degradation of POSs and increased lysosomal exocytosis contribute to the formation of BLamDs seen in LAMP2-deficient mice.
Loss of LAMP2 Expression and Accumulation of Vacuolar Structures in Human AMD.
Finally, we examined LAMP2 expression in human eyes. Previously it had been shown that LAMP2 is strongly expressed in lysosomes of the human RPE (33). Patients with LAMP2 deficiency manifest widespread retinopathy and maculopathy with irregularities in the RPE photoreceptor complex relatively early in life (31–34, 54). Confirming a prior report (33), LAMP2 immunoreactivity was primarily detected in the RPE rather than in the retina (Fig. 8A). Furthermore, LAMP2 expression appeared to be decreased in AMD specimens relative to normal eyes (Fig. 8 B and C), while staining with an antibody against RPE65 revealed similar immunoreactivity between AMD and controls (Fig. 8D). TEM revealed largely dilated autophagic or phagocytic vacuoles in the RPE from AMD patients, as well as abundant granular electron-dense material within drusen under the RPE (SI Appendix, Fig. S8), reminiscent of intracellular changes found in the RPE from aged LAMP2-deficient mice. Taken together, these results indicate an association between reduced LAMP2 expression and AMD.
Discussion
Our work revealed a role for deficient lysosomal LAMP2 expression by the RPE in the formation of extracellular RPE deposits resembling BLamDs in AMD. There are several hypotheses on the origin of extracellular RPE deposits, including the lipid retention/“oil spill” hypothesis for BLinD and drusen formation (55), misfolding and aberrant accumulation of extracellular matrix proteins (56, 57), and immune complex formation (58, 59). Here, we provide an additional mechanism related to the reduced expression of LAMP2 and dysregulated lysosomal function in aged RPE cells that may contribute to BLamD formation.
LAMP2 is preferentially expressed in the RPE, and its expression decreases with age in mouse as well as in human AMD. Moreover, the ablation of the Lamp2 gene in vivo results in age-dependent BrM thickening and BLamD accumulation. In addition, several key molecules found in human drusen, including APOE, APOA1, clusterin, vitronectin, and cholesterol, were detected adjacent to BLamDs in LAMP2-deficient mice. Importantly, we noted similar amorphous and granular extracellular material beneath the RPE in human AMD and in Lamp2 KO mice by electron microscopy. Several features observed in Lamp2 KO mice share apparent similarities with human AMD, supporting the idea that a diminution of LAMP2 expression in mice mimics BLamD formation in humans. BLamDs form in many conditions including AMD (44, 60, 61). Mechanistically, we observed that LAMP2 deficiency could recapitulate the accumulation of sub-RPE deposits even in the absence of photoreceptors, although this was worsened by the addition of POSs for phagocytosis in ex vivo cultures of the mouse RPE, suggesting that the deficient phagocytic capabilities of the RPE contributed to the formation of BLamDs. In addition, siRNA-mediated silencing of Lamp2 in vitro resulted in up-regulated lysosomal exocytosis, showing that an increase in exocytosis of indigestible cargo might contribute to the accumulation of extracellular deposits seen in LAMP2 deficiency.
Loss of LAMP2 in mouse eyes also resulted in an increase in autofluorescent properties in RPE cells. In the Lamp2 KO RPE, nearly spherical inclusions were observed, accompanied by lipid droplets stained with oil red O. These features, observed here and in other mouse models (21, 44, 62), are not identical to those seen in the human RPE, where lipofuscin is associated with complex granules that interact with melanosomes and melanolipofuscin (63). Although BLamDs and the accumulation of lipids/lipoproteins support an AMD-like pathology in Lamp2 KO mice, the autofluorescent granules in mouse models may differ from human lipofuscin.
Several studies have examined the role of autophagy-related genes and proteins in the RPE and AMD (16, 19–21, 64, 65). Wang et al. (17) observed increased exosomal markers and ATG5 in the drusen of AMD patients and speculated that increased autophagy may contribute to the formation of drusen. However, in our study cellular debris was accumulating beneath the RPE from Lamp2 KO mice, suggesting rather that insufficient autophagic maturation contributes to the accumulation of sub-RPE deposits. Contrasting with the age-dependent decline in LAMP2 (which is involved in the late stages of autophagy) reported here, Mitter et al. (18) showed an age-dependent increase in ATG7 and ATG9, 2 proteins which are involved in the earlier steps of autophagy, in the human central retina outside the macula. However, the authors observed that AMD patients were affected by a reduction in these autophagy-related proteins, leading to speculation that increased autophagy in aging would constitute a protective mechanism that is lost in AMD patients (18). More recently, Yao et al. (21) reported that deletion of the Unc-51–like autophagy activating kinase (ULK) interacting protein RB1CC1, which is required for the very first steps of autophagy induction (among other processes such as cell proliferation and apoptosis), caused RPE degeneration and subsequent loss of photoreceptors in mice. The accumulation of deposits seen in that study was primarily intra-RPE and subretinal rather than BLamDs as reported here. Since FIP200/RB1CC1 (in contrast to ATG5, ATG13, and Beclin 1) is not involved in LAP (16), this phenotype may be ascribed to an exclusive inhibition of macroautophagy, not LAP (66). Taken together, BLamDs occurring in Lamp2 KO eyes might be due to LAP inhibition and consequent phagocytic dysfunction, beyond a macroautophagy defect. This interpretation is in line with the observation that POS feeding to the cultured Lamp2 KO RPE led to extracellular deposits on the basal membrane.
Valapala et al. reported that deletion of the lens crystalline gene Cryba1, which is also expressed outside the lens, resulted in impaired endolysosomal acidification via V-ATPase-MTORC1 signaling and RPE degeneration (19, 67). Here, we observed RPE degeneration in the context of LAMP2 deficiency, which does not impair lysosomal acidification (24–26). Our results are consistent with previous studies in that compromised lysosomal degradation may yield RPE dysfunction. However, in contrast to the study by Valapala et al., where RPE degeneration was observed without detectable sub-RPE deposits, we did observe massive sub-RPE deposits in the context of LAMP2 deficiency.
LAMP2 is implicated in subtypes of autophagy including chaperone-mediated autophagy (CMA), which specifically depends on the LAMP2A isoform, 1 of 3 products generated by alternative splicing of the LAMP2/Lamp2 gene. LAMP2A possesses a highly glycosylated luminal region that is common to all LAMP2 isoforms and a specific 11-amino-acid-long cytosolic C-terminal tail (69). By virtue of this particularity, LAMP2A (but neither of the 2 other isoforms, LAMP2B and LAMP2C), participates in CMA, which facilitates selective import and degradation of cytosolic proteins in lysosomes via chaperoning of heat shock 70-kDa protein 8 (70–73). Complete knockout of all LAMP2 isoforms in mice affects macroautophagy (24, 74), but does not affect clearance of CMA substrates in certain assays of brain lysates from Lamp2 KO mice or after stable knockdown of Lamp2 in murine neuroblastoma (N2a) cells (74). Furthermore, studies have shown normal proteolysis in vitro in mouse embryonic fibroblasts obtained from embryonic lethal Lamp-1/2 double-KO mice (27, 75). Thus, further investigation will be required to elucidate the potential role of LAMP2 isoforms and CMA in retinal pathophysiology. Another poorly explored question regarding the structure/function of LAMP2 is the role of its N-terminal domain, which is common to all LAMP2 isoforms. Previous studies using LAMP1/2-double-deficient MEFs revealed disturbed cholesterol trafficking in LAMP2-deficient cells that depends on the domain common to all LAMP2 isoforms (27). LAMP2 has been consistently shown to interact with cholesterol, as well as with NPC1 (Niemann-Pick disease, type C1) and NPC2 (76), which are proteins that are involved in intracellular cholesterol trafficking.
In parallel with the findings in LAMP2 KO mice, loss-of-function mutations in the LAMP2 gene are known to cause Danon disease in humans, which is associated with the accumulation of autophagic vacuoles in various cell types such as cardiomyocytes and myocytes (29, 30). Danon patients are known to suffer from the classical triad of cardiomyopathy, skeletal myopathy, and mental retardation. Moreover, recent studies have demonstrated that patients with Danon disease exhibit progressive and widespread retinal and macular degeneration that shares some similarities with changes observed in AMD, such as pigmentary disturbances and discrete sub-RPE deposits, although it should be noted that all of these patients were young (32–34, 31). Our finding of decreased LAMP2 expression and increased abnormally dilated vacuoles in the RPE of elderly human AMD patients, along with animal data, suggests that local LAMP2 deficiency plays a role in sub-RPE deposits in AMD.
In summary, our results reveal a role for lysosomal LAMP2 in RPE function, sub-RPE basolaminar deposit formation, and AMD pathology. LAMP2 is preferentially expressed in the RPE, and its genetic deficiency leads to the formation of a specific form of sub-RPE deposits (BLamDs) as well as the accumulation of proteins and lipids adjacent to the deposits whose features resemble features of human AMD. Speculatively, these results support stimulation of LAMP2 expression and function as an additional interventional strategy in AMD.
Materials and Methods
Donor human eyes were obtained from the National Disease Research Interchange (Philadelphia, PA). Adult male Lamp2 KO mice (Lamp2y/−) (24), their WT littermates (Lamp2y/+), or C57BL6J mice (Stock No. 000664, Jackson laboratory) were used at 2, 6, and 12 mo of age in this study. Extensive materials and methods regarding fundus photography, immunohistochemistry, ex vivo RPE culture, TEM, and Western blot are provided in SI Appendix, SI Materials and Methods.
Supplementary Material
Acknowledgments
We thank Philip Seifert (Schepens Eye Research Institute) and Fumiyo Morikawa (Kyushu University) for their technical assistance and Wendy Chao (Massachusetts Eye and Ear Infirmary) for her support in critical review. This work was supported by the Robert Machemer Foundation Vitreoretinal Research Scholarship (S.N.); the Foundation Lions Eye Research Fund; the Yeatts Family Foundation; a 2013 Macula Society Research Grant award; a Research to Prevent Blindness Physician Scientist Award; an unrestricted grant from the Research to Prevent Blindness Foundation; the National Eye Institute (NEI) (grant nos. R21EY023079-01/A1 and EY014104 [a MEEI Core Grant]); the Loeffler Family fund; R01EY025362-01; an Alcon Research Institute (ARI) Young Investigator Award; a National Institutes of Health (NIH) NEI Core grant (grant no. P30EY003790); the Agence National de la Recherche (ANR), the ERA-Net for Research on Rare Diseases, the Institut Universitaire de France; and a Grant-in-Aid for Young Scientists (Grant no. 19K18880), Japan Society for the Promotion of Science.
Footnotes
The authors declare no competing interest.
This article is a PNAS Direct Submission. C.A.C. is a guest editor invited by the Editorial Board.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1906643116/-/DCSupplemental.
References
- 1.Jager R. D., Mieler W. F., Miller J. W., Age-related macular degeneration. N. Engl. J. Med. 358, 2606–2617 (2008). [DOI] [PubMed] [Google Scholar]
- 2.Miller J. W., Le Couter J., Strauss E. C., Ferrara N., Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology 120, 106–114 (2013). [DOI] [PubMed] [Google Scholar]
- 3.Ambati J., Fowler B. J., Mechanisms of age-related macular degeneration. Neuron 75, 26–39 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ambati J., Atkinson J. P., Gelfand B. D., Immunology of age-related macular degeneration. Nat. Rev. Immunol. 13, 438–451 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ferris F. L., 3rd, et al. ; Beckman Initiative for Macular Research Classification Committee , Clinical classification of age-related macular degeneration. Ophthalmology 120, 844–851 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Curcio C. A., Soft drusen in age-related macular degeneration: Biology and targeting via the oil spill strategies. Invest. Ophthalmol. Vis. Sci. 59, AMD160–AMD181 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sarks J. P., Sarks S. H., Killingsworth M. C., Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond.) 2, 552–577 (1988). [DOI] [PubMed] [Google Scholar]
- 8.Kennedy C. J., Rakoczy P. E., Constable I. J., Lipofuscin of the retinal pigment epithelium: A review. Eye (Lond.) 9, 763–771 (1995). [DOI] [PubMed] [Google Scholar]
- 9.Marmorstein A. D., Marmorstein L. Y., Sakaguchi H., Hollyfield J. G., Spectral profiling of autofluorescence associated with lipofuscin, Bruch’s membrane, and sub-RPE deposits in normal and AMD eyes. Invest. Ophthalmol. Vis. Sci. 43, 2435–2441 (2002). [PubMed] [Google Scholar]
- 10.Tong Y., et al. , Hyperspectral autofluorescence imaging of drusen and retinal pigment epithelium in donor eyes with age-related macular degeneration. Retina 36 (suppl. 1), S127–S136 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Rudolf M., et al. , Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest. Ophthalmol. Vis. Sci. 49, 1200–1209 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ach T., et al. , Autofluorescence imaging of human RPE cell granules using structured illumination microscopy. Br. J. Ophthalmol. 96, 1141–1144 (2012). [DOI] [PubMed] [Google Scholar]
- 13.Reiter G. S., et al. , Impact of drusen volume on quantitative fundus autofluorescence in early and intermediate age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 60, 1937–1942 (2019). [DOI] [PubMed] [Google Scholar]
- 14.Pilgrim M. G., et al. , Subretinal pigment epithelial deposition of drusen components including hydroxyapatite in a primary cell culture model. Invest. Ophthalmol. Vis. Sci. 58, 708–719 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Krohne T. U., Holz F. G., Kopitz J., Apical-to-basolateral transcytosis of photoreceptor outer segments induced by lipid peroxidation products in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 51, 553–560 (2010). [DOI] [PubMed] [Google Scholar]
- 16.Kim J. Y., et al. , Noncanonical autophagy promotes the visual cycle. Cell 154, 365–376 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wang A. L., et al. , Autophagy and exosomes in the aged retinal pigment epithelium: Possible relevance to drusen formation and age-related macular degeneration. PLoS One 4, e4160 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Mitter S. K., et al. , Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD. Autophagy 10, 1989–2005 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Valapala M., et al. , Lysosomal-mediated waste clearance in retinal pigment epithelial cells is regulated by CRYBA1/βA3/A1-crystallin via V-ATPase-MTORC1 signaling. Autophagy 10, 480–496 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Yao J., et al. , Circadian and noncircadian modulation of autophagy in photoreceptors and retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 55, 3237–3246 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Yao J., et al. , Deletion of autophagy inducer RB1CC1 results in degeneration of the retinal pigment epithelium. Autophagy 11, 939–953 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Binker M. G., et al. , Arrested maturation of Neisseria-containing phagosomes in the absence of the lysosome-associated membrane proteins, LAMP-1 and LAMP-2. Cell Microbiol. 9, 2153–2166 (2007). [DOI] [PubMed] [Google Scholar]
- 23.Andrejewski N., et al. , Normal lysosomal morphology and function in LAMP-1-deficient mice. J. Biol. Chem. 274, 12692–12701 (1999). [DOI] [PubMed] [Google Scholar]
- 24.Tanaka Y., et al. , Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 406, 902–906 (2000). [DOI] [PubMed] [Google Scholar]
- 25.Eskelinen E. L., et al. , Role of LAMP-2 in lysosome biogenesis and autophagy. Mol. Biol. Cell 13, 3355–3368 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Huynh K. K., et al. , LAMP proteins are required for fusion of lysosomes with phagosomes. EMBO J. 26, 313–324 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Eskelinen E. L., et al. , Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts. Mol. Biol. Cell 15, 3132–3145 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Saftig P., Beertsen W., Eskelinen E. L., LAMP-2: A control step for phagosome and autophagosome maturation. Autophagy 4, 510–512 (2008). [DOI] [PubMed] [Google Scholar]
- 29.Nishino I., et al. , Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406, 906–910 (2000). [DOI] [PubMed] [Google Scholar]
- 30.Malicdan M. C., Noguchi S., Nonaka I., Saftig P., Nishino I., Lysosomal myopathies: An excessive build-up in autophagosomes is too much to handle. Neuromuscul. Disord. 18, 521–529 (2008). [DOI] [PubMed] [Google Scholar]
- 31.Thompson D. A., Constable P. A., Liasis A., Walters B., Esteban M. T., The physiology of the retinal pigment epithelium in Danon disease. Retina 36, 629–638 (2016). [DOI] [PubMed] [Google Scholar]
- 32.Prall F. R., et al. , Ophthalmic manifestations of Danon disease. Ophthalmology 113, 1010–1013 (2006). [DOI] [PubMed] [Google Scholar]
- 33.Schorderet D. F., et al. , Retinopathy in Danon disease. Arch. Ophthalmol. 125, 231–236 (2007). [DOI] [PubMed] [Google Scholar]
- 34.Thiadens A. A., et al. , Cone-rod dystrophy can be a manifestation of Danon disease. Graefes Arch. Clin. Exp. Ophthalmol. 250, 769–774 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Howe C. L., et al. , Derived protein sequence, oligosaccharides, and membrane insertion of the 120-kDa lysosomal membrane glycoprotein (lgp120): Identification of a highly conserved family of lysosomal membrane glycoproteins. Proc. Natl. Acad. Sci. U.S.A. 85, 7577–7581 (1988). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Xu H., Chen M., Manivannan A., Lois N., Forrester J. V., Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell 7, 58–68 (2008). [DOI] [PubMed] [Google Scholar]
- 37.Chen M., Forrester J. V., Xu H., Dysregulation in retinal para-inflammation and age-related retinal degeneration in CCL2 or CCR2 deficient mice. PLoS One 6, e22818 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Xu H., Chen M., Forrester J. V., Para-inflammation in the aging retina. Prog. Retin. Eye Res. 28, 348–368 (2009). [DOI] [PubMed] [Google Scholar]
- 39.Curcio C. A., Millican C. L., Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch. Ophthalmol. 117, 329–339 (1999). [DOI] [PubMed] [Google Scholar]
- 40.Sarks J. P., Sarks S. H., Killingsworth M. C., Evolution of soft drusen in age-related macular degeneration. Eye (Lond.) 8, 269–283 (1994). [DOI] [PubMed] [Google Scholar]
- 41.Sarks S., Cherepanoff S., Killingsworth M., Sarks J., Relationship of basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 48, 968–977 (2007). [DOI] [PubMed] [Google Scholar]
- 42.Balaratnasingam C., et al. , Cuticular drusen: Clinical phenotypes and natural history defined using multimodal imaging. Ophthalmology 125, 100–118 (2018). [DOI] [PubMed] [Google Scholar]
- 43.Curcio C. A., Presley J. B., Millican C. L., Medeiros N. E., Basal deposits and drusen in eyes with age-related maculopathy: Evidence for solid lipid particles. Exp. Eye Res. 80, 761–775 (2005). [DOI] [PubMed] [Google Scholar]
- 44.Jiang M., et al. , Microtubule motors transport phagosomes in the RPE, and lack of KLC1 leads to AMD-like pathogenesis. J. Cell Biol. 210, 595–611 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Okubo A., et al. , The relationships of age changes in retinal pigment epithelium and Bruch’s membrane. Invest. Ophthalmol. Vis. Sci. 40, 443–449 (1999). [PubMed] [Google Scholar]
- 46.Guymer R., Luthert P., Bird A., Changes in Bruch’s membrane and related structures with age. Prog. Retin. Eye Res. 18, 59–90 (1999). [DOI] [PubMed] [Google Scholar]
- 47.Curcio C. A., Medeiros N. E., Millican C. L., Photoreceptor loss in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 37, 1236–1249 (1996). [PubMed] [Google Scholar]
- 48.Zanzottera E. C., et al. , The project MACULA retinal pigment epithelium grading system for histology and optical coherence tomography in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 56, 3253–3268 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Wood A., et al. , Retinal and choroidal thickness in early age-related macular degeneration. Am. J. Ophthalmol. 152, 1030–1038.e2 (2011). [DOI] [PubMed] [Google Scholar]
- 50.Curcio C. A., Millican C. L., Bailey T., Kruth H. S., Accumulation of cholesterol with age in human Bruch’s membrane. Invest. Ophthalmol. Vis. Sci. 42, 265–274 (2001). [PubMed] [Google Scholar]
- 51.Curcio C. A., et al. , Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp. Eye Res. 81, 731–741 (2005). [DOI] [PubMed] [Google Scholar]
- 52.Redmond T. M., et al. , Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat. Genet. 20, 344–351 (1998). [DOI] [PubMed] [Google Scholar]
- 53.Tang P. H., Fan J., Goletz P. W., Wheless L., Crouch R. K., Effective and sustained delivery of hydrophobic retinoids to photoreceptors. Invest. Ophthalmol. Vis. Sci. 51, 5958–5964 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Laforêt P., et al. , Charcot-Marie-Tooth features and maculopathy in a patient with Danon disease. Neurology 63, 1535 (2004). [DOI] [PubMed] [Google Scholar]
- 55.Curcio C. A., Johnson M., Rudolf M., Huang J. D., The oil spill in ageing Bruch membrane. Br. J. Ophthalmol. 95, 1638–1645 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Marmorstein L. Y., et al. , Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 99, 13067–13072 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Fu L., et al. , The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum. Mol. Genet. 16, 2411–2422 (2007). [DOI] [PubMed] [Google Scholar]
- 58.Johnson L. V., Ozaki S., Staples M. K., Erickson P. A., Anderson D. H., A potential role for immune complex pathogenesis in drusen formation. Exp. Eye Res. 70, 441–449 (2000). [DOI] [PubMed] [Google Scholar]
- 59.Johnson L. V., Leitner W. P., Staples M. K., Anderson D. H., Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp. Eye Res. 73, 887–896 (2001). [DOI] [PubMed] [Google Scholar]
- 60.Espinosa-Heidmann D. G., et al. , Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Invest. Ophthalmol. Vis. Sci. 47, 729–737 (2006). [DOI] [PubMed] [Google Scholar]
- 61.Marmorstein L. Y., McLaughlin P. J., Peachey N. S., Sasaki T., Marmorstein A. D., formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: A model for the early pathogenic course of macular degeneration. Hum. Mol. Genet. 16, 2423–2432 (2007). [DOI] [PubMed] [Google Scholar]
- 62.Zhao Z., et al. , Age-related retinopathy in NRF2-deficient mice. PLoS One 6, e19456 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Pollreisz A., et al. , Visualizing melanosomes, lipofuscin, and melanolipofuscin in human retinal pigment epithelium using serial block face scanning electron microscopy. Exp. Eye Res. 166, 131–139 (2018). [DOI] [PubMed] [Google Scholar]
- 64.Frost L. S., Mitchell C. H., Boesze-Battaglia K., Autophagy in the eye: Implications for ocular cell health. Exp. Eye Res. 124, 56–66 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Frost L. S., et al. , The contribution of melanoregulin to microtubule-associated protein 1 light chain 3 (LC3) associated phagocytosis in retinal pigment epithelium. Mol. Neurobiol. 52, 1135–1151 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Martinez J., et al. , Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the efficient clearance of dead cells. Proc. Natl. Acad. Sci. U.S.A. 108, 17396–17401 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Valapala M., et al. , Modulation of V-ATPase by βA3/A1-Crystallin in retinal pigment epithelial cells. Adv. Exp. Med. Biol. 854, 779–784 (2016). [DOI] [PubMed] [Google Scholar]
- 68.Zigler J. S. Jr, Sinha D., βA3/A1-crystallin: More than a lens protein. Prog. Retin. Eye Res. 44, 62–85 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Cuervo A. M., Wong E., Chaperone-mediated autophagy: Roles in disease and aging. Cell Res. 24, 92–104 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Cuervo A. M., Dice J. F., Age-related decline in chaperone-mediated autophagy. J. Biol. Chem. 275, 31505–31513 (2000). [DOI] [PubMed] [Google Scholar]
- 71.Cuervo A. M., et al. , Autophagy and aging: The importance of maintaining “clean” cells. Autophagy 1, 131–140 (2005). [DOI] [PubMed] [Google Scholar]
- 72.Kiffin R., et al. , Altered dynamics of the lysosomal receptor for chaperone-mediated autophagy with age. J. Cell Sci. 120, 782–791 (2007). [DOI] [PubMed] [Google Scholar]
- 73.Fujiwara Y., et al. , Discovery of a novel type of autophagy targeting RNA. Autophagy 9, 403–409 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Rothaug M., et al. , LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease. Acta Neuropathol. Commun. 3, 6 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Wang G., Mao Z., Chaperone-mediated autophagy: Roles in neurodegeneration. Transl. Neurodegener. 3, 20 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Li J., Pfeffer S. R., Lysosomal membrane glycoproteins bind cholesterol and contribute to lysosomal cholesterol export. eLife 5, e21635 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.